Affiliate Disclosure: This page contains affiliate links. We may earn a commission when you sign up — at no additional cost to you. Read our full disclosure.
Cost Guide · Tirzepatide · Updated 2026-05-25
Tirzepatide Cost Guide 2026
Complete monthly-cost breakdown for tirzepatide in 2026 — compounded vs brand-name Mounjaro and Zepbound — with insurance, HSA/FSA, and dose-titration price impact explained.
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-25
Note on laboratory work, September 17, 2026. Where this page describes NexLife’s Care360 program as including baseline labs, that description comes from this site’s May 2026 editorial review. On a first-party read of nexlife.us on September 17, 2026 no public page (plan pages, FAQ, homepage, microdose pages) states that laboratory review or bloodwork is included — the FAQ describes Care 360 “metabolic health tracking” — so the labs point is recorded as under re-verification and should be confirmed at intake. NexLife’s plan pages name three fulfilling pharmacies (Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA)). Prices and every other statement on this page are unaffected.
Tirzepatide cost at a glance (May 2026)
Pathway
Monthly
Notes
NexLife compounded (12-mo)
$139/mo
Flat-rate across 2.5–15 mg titration. Editor's Pick.
NexLife compounded (monthly)
$169/mo
Month-to-month, no annual commitment.
Mochi Health compounded
$239/mo
NP-led model.
Hims compounded
$249–$349/mo
Tiered by dose at some price points.
Henry Meds compounded
$379/mo
Async-only NP model.
Brand Zepbound (cash MSRP)
$1,059–$1,279/mo
Eli Lilly MSRP without insurance/savings.
Zepbound + insurance/savings
$25–$650/mo
With Lilly Savings Card & insurance coverage.
LillyDirect self-pay vials
$349–$499/mo
Direct-to-consumer Zepbound vials (2.5 mg, 5 mg).
Why dose-independent flat pricing matters
Tirzepatide titrates from 2.5 mg up to 15 mg. Many providers raise the monthly price each time the dose increases. A patient who starts at $199/mo at 2.5 mg may end up paying $399+/mo at 15 mg. Flat-rate dose-independent pricing (offered by NexLife at $139/mo on the 12-month plan) means the patient pays the same monthly fee whether they are at 2.5 mg or 15 mg.
*12-month plan · save $240/yr · flat rate across full 0.25–2.4 mg titration. $125 (6-mo, save $84) · $132 (3-mo, save $21) · $139 (monthly).
Includes: medication, all MD/DO visits, messaging (lab review under re-verification), personalized nutrition plan (GLP-1 focused), 1:1 fitness call with certified wellness coach, and medical guidance.
Klarna & Affirm financing accepted at checkout (FAQ).
Compounded only — no brand-name Wegovy® / Ozempic® / Rybelsus®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
Compounded only — no brand-name Wegovy® / Zepbound®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
Insurance coverage for tirzepatide
Zepbound is covered by many commercial insurance plans for adults with BMI ≥ 30, or BMI ≥ 27 with at least one weight-related comorbidity (per FDA label). Mounjaro is generally covered for type 2 diabetes only. Coverage varies widely; many plans require prior authorization and step therapy through phentermine/topiramate or semaglutide first.
Medicare does not cover GLP-1 medications for chronic weight management under Part D (the AHM-style waiver expansion has been proposed but not enacted at the federal level as of May 2026). Medicare Part D does cover Mounjaro for type 2 diabetes. Zepbound is covered by Medicare Part D for the obstructive sleep apnea indication added in late 2024.
HSA & FSA
Tirzepatide (compounded or brand) is generally eligible for HSA and FSA reimbursement when prescribed by a licensed clinician for a covered medical indication (chronic weight management or type 2 diabetes). Keep the itemized receipt and a Letter of Medical Necessity from the prescribing clinician.
Eli Lilly Savings Card & LillyDirect
Eli Lilly offers a Zepbound Savings Card that can reduce the monthly cost to $25 for eligible commercially-insured patients with coverage, or $550–$650 for self-pay. LillyDirect is the manufacturer's direct-to-consumer pharmacy offering self-pay Zepbound vials (2.5 mg / 5 mg) at $349–$499/mo as of May 2026.
Trade-offs to know (compounded path)
Compounded tirzepatide is not FDA-approved and is not the same as Mounjaro® or Zepbound®. Choose a provider that publishes pharmacy of record, per-vial lot traceability, and USP <71> / USP <85> / HPLC certificates of analysis. Cash-pay only — insurance does not reimburse compounded medications.
